Results 191 to 200 of about 94,073 (238)

Latent JAK2 V617F-Positive Myeloproliferative Neoplasm With Normal Blood Counts and Recurrent Splanchnic Vein Thrombosis in a Young Woman. [PDF]

Cureus
Thida AM, Luhrs C, Baral A, Zhonghua L, Brown J.   +4 more
europepmc   +1 more source

Differential regulation of mTORC2 signalling by type I and type II calreticulin (CALR) driver mutations of myeloproliferative neoplasm. [PDF]

Cell Commun Signal
Naseer S, Singh A, Shrivastva S, Singh RK, Chowdhury S, Dey CS, Roy A.   +6 more
europepmc   +1 more source

Shaping the Future of Myeloproliferative Neoplasm Therapy: Immune-Based Strategies and Targeted Innovations. [PDF]

Cancers (Basel)
Carturan A, Morè S, Poloni A, Rupoli S, Morsia E.   +4 more
europepmc   +1 more source

Molecular Profile of BCR-ABL1 Negative Myeloproliferative Neoplasm in a Moroccan Population. [PDF]

Asian Pac J Cancer Prev
Soro SGC, Amalou G, Benchikh S, El Hamouchi A, Charoute H, Oukheda M, Abdelouaheb BB, Saile R, Lebrazi H, Nassereddine S.   +9 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Myelodysplastic/Myeloproliferative Neoplasms

Seminars in Diagnostic Pathology, 2011
The myelodysplastic/myeloproliferative neoplasms (MDS/MPN) include clonal myeloid neoplasms that overlap the MDS and MPN categories and at the time of initial diagnosis exhibit some clinical, laboratory, or morphologic features supporting the diagnosis of myelodysplastic syndrome (MDS) and at the same time show proliferative features in keeping with ...
Elizabeth, Hyjek, James W, Vardiman
openaire   +5 more sources

Thrombosis in Myeloproliferative Neoplasms

Seminars in Thrombosis and Hemostasis, 2014
Thrombotic events are very frequent and represent the main cause of morbidity and mortality in patients with Philadelphia chromosome-negative myeloproliferative neoplasms (MPNs), mainly polycythemia vera and essential thrombocythemia. Pathogenesis of blood clotting activation in these diseases is multifactorial, and it involves various abnormalities of
Marina Marchetti, Anna Falanga
exaly   +4 more sources

Pediatric Myeloproliferative Neoplasms

Clinics in Laboratory Medicine, 2021
Myeloproliferative neoplasms can present early in life and may present a diagnostic challenge. Very few studies have focused on the diagnosis, prognosis, and therapy for pediatric myeloproliferative neoplasms. This article focuses on chronic myeloid leukemia, essential thrombocythemia, polycythemia vera, and primary myelofibrosis in children.
Farah, El-Sharkawy, Elizabeth, Margolskee   +1 more
openaire   +2 more sources

Myeloproliferative Neoplasms with Monocytosis

Current Hematologic Malignancy Reports, 2021
Myeloproliferative neoplasms (MPN) are a heterogeneous group of hematopoietic stem cell neoplasms comprising of polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF) that share driver mutations (JAK2/CALR/MPL) resulting in constitutive activation of JAK/STAT and other signaling pathways.
Erika Morsia, Naseema Gangat
openaire   +2 more sources